Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs. By Gina Kolata and Rebecca Robbins A daily pill may be as ...

Eli Lilly announced Thursday the successful completion of a phase 3 trial of Orforglipron – the first small-molecule GLP-1 that is administered as a once-daily oral pill. The ACHIEVE-1 trial ...

"The red pill is like, 'I see the truth.' It’s a call to action by the manosphere,” Adam, played by Amari Bacchus, says in the show about an Instagram comment. “She’s saying he’s an ...

A new pill given the green light for NHS use offers "new hope" to those living with bladder cancer. The drug, called erdafitinib, has been recommended for use on the NHS by the National Institute ...

President Trump's new tariffs are the largest in a century and treat some adversaries better than America's allies. Photo: Mandel Nganpedro Pardo/AFP/Getty Images A supply chain is only as strong ...

Eli Lilly & Co. shares surged after its experimental pill helped patients shed weight and control blood sugar about as well as Ozempic, an advance that could turbocharge what’s already one of ...

Many of John Green’s novels offer a snapshot of young adult reading culture in the 2010s – star-crossed teenage lovers and “manic pixie dream girl” characters, Tumblr quotes and metaphors ...

after the drugmaker reported positive results from a late-stage trial of a GLP-1 treatment for Type 2 diabetes and obesity in pill form. The last time the stock rose as much was June 29 ...

What Are Birth Control Pills? Birth control pills are contraceptives that use hormones to prevent a pregnancy. There are many methods of birth control. You may hear this specific one referred to ...

A twice-daily pill has been approved for use on the NHS that could slow disease progression in cancer patients "in desperate need" of better treatment options. The drug, called capivasertib ...

Eli Lilly on Thursday said its daily obesity pill met the company's goals in the first of several late-stage trials, helping patients with Type 2 diabetes lower their blood sugar and body weight ...